Enterprise Value
339.2M
Cash
117.4M
Avg Qtr Burn
-10.93M
Short % of Float
13.57%
Insider Ownership
6.51%
Institutional Own.
69.09%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Furoscix (furosemide) Details Heart failure | Approved Quarterly sales |